466 related items for PubMed ID: 9215245
21. Importance of the inhalation device on the effect of budesonide.
Agertoft L, Pedersen S.
Arch Dis Child; 1993 Jul; 69(1):130-3. PubMed ID: 8024295
[Abstract] [Full Text] [Related]
22. Comparison of the antiasthmatic, oropharyngeal, and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbuhaler dry powder inhaler.
Toogood JH, White FA, Baskerville JC, Fraher LJ, Jennings B.
J Allergy Clin Immunol; 1997 Feb; 99(2):186-93. PubMed ID: 9042043
[Abstract] [Full Text] [Related]
23. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM, Boulet LP, Follows RM.
Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
[Abstract] [Full Text] [Related]
24. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide.
Ferguson AC, Spier S, Manjra A, Versteegh FG, Mark S, Zhang P.
J Pediatr; 1999 Apr; 134(4):422-7. PubMed ID: 10190915
[Abstract] [Full Text] [Related]
25. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
Medley H, Orozco S, Allen A.
Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
[Abstract] [Full Text] [Related]
26. An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers.
Grahnén A, Eckernäs SA, Brundin RM, Ling-Andersson A.
Br J Clin Pharmacol; 1994 Dec; 38(6):521-5. PubMed ID: 7888290
[Abstract] [Full Text] [Related]
27. Budesonide treatment of moderate and severe asthma in children: a dose-response study.
Pedersen S, Hansen OR.
J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):29-33. PubMed ID: 7822661
[Abstract] [Full Text] [Related]
28. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[Abstract] [Full Text] [Related]
29. A comparison of the efficacy and safety of a half dose of fluticasone propionate with beclamethasone dipropionate and budesonide in childhood asthma.
Karakoç F, Karadag B, Kut A, Ersu R, Bakaç S, Cebeci D, Dagli E.
J Asthma; 2001 May; 38(3):229-37. PubMed ID: 11392363
[Abstract] [Full Text] [Related]
30. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
Markham A, Jarvis B.
Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
[Abstract] [Full Text] [Related]
31. A comparative study of inhaled ciclesonide 160 microg/day and fluticasone propionate 176 microg/day in children with asthma.
Pedersen S, Garcia Garcia ML, Manjra A, Theron I, Engelstätter R.
Pediatr Pulmonol; 2006 Oct; 41(10):954-61. PubMed ID: 16868976
[Abstract] [Full Text] [Related]
32. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma.
Bateman ED, Linnhof AE, Homik L, Freudensprung U, Smau L, Engelstätter R.
Pulm Pharmacol Ther; 2008 Oct; 21(2):264-75. PubMed ID: 17604664
[Abstract] [Full Text] [Related]
33. A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma.
Wasserman SI, Gross GN, Schoenwetter WF, Munk ZM, Kral KM, Schaberg A, Kellerman DJ.
J Asthma; 1996 Oct; 33(4):265-74. PubMed ID: 8707781
[Abstract] [Full Text] [Related]
34. Fluticasone propionate in asthma: a long term dose comparison study.
Verona E, Petrov D, Cserhati E, Hofman J, Geppe N, Medley H, Hughes S.
Arch Dis Child; 2003 Jun; 88(6):503-9. PubMed ID: 12765916
[Abstract] [Full Text] [Related]
35. Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma.
Shapiro G, Bronsky EA, LaForce CF, Mendelson L, Pearlman D, Schwartz RH, Szefler SJ.
J Pediatr; 1998 Jun; 132(6):976-82. PubMed ID: 9627589
[Abstract] [Full Text] [Related]
36. Potency ratio fluticasone propionate (Flixotide Diskus)/budesonide (Pulmicort Turbuhaler).
Ställberg B, Pilman E, Skoogh BE, Hermansson BA.
Respir Med; 2007 Mar; 101(3):610-5. PubMed ID: 16889952
[Abstract] [Full Text] [Related]
37. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
Harrison TW, Wisniewski A, Honour J, Tattersfield AE.
Thorax; 2001 Mar; 56(3):186-91. PubMed ID: 11182010
[Abstract] [Full Text] [Related]
38. Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function.
Nielsen LP, Dahl R.
Am J Respir Crit Care Med; 2000 Dec; 162(6):2053-7. PubMed ID: 11112113
[Abstract] [Full Text] [Related]
39. High-dose inhaled budesonide may substitute for oral therapy after an acute asthma attack.
Nana A, Youngchaiyud P, Charoenratanakul S, Boe J, Löfdahl CG, Selroos O, Ståhl E.
J Asthma; 1998 Dec; 35(8):647-55. PubMed ID: 9860085
[Abstract] [Full Text] [Related]
40. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
Fowler SJ, Currie GP, Lipworth BJ.
J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
